Literature DB >> 33559517

Management of hemophagocytic lymphohistiocytosis (HLH) associated with chimeric antigen receptor T-cell (CAR-T) therapy using anti-cytokine therapy: an illustrative case and review of the literature.

Ajay Major1, Jennifer Collins1, Caroline Craney1, Alisa K Heitman1, Emily Bauer1, Elizabeth Zerante1, Wendy Stock2, Michael R Bishop2, Jagoda Jasielec2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33559517      PMCID： PMC8282706          DOI： 10.1080/10428194.2021.1881507

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  14 in total

1.  Myeloma CAR-T CRS Management With IL-1R Antagonist Anakinra.

Authors:  Shashidhar S Jatiani; Adolfo Aleman; Deepu Madduri; Ajai Chari; Hearn Jay Cho; Shambavi Richard; Joshua Richter; Joshua Brody; Sundar Jagannath; Samir Parekh
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2020-05-11

2.  Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma.

Authors:  Paolo Strati; Sairah Ahmed; Partow Kebriaei; Loretta J Nastoupil; Catherine M Claussen; Grace Watson; Sandra B Horowitz; Anne Rain T Brown; Bryan Do; Maria A Rodriguez; Ranjit Nair; Elizabeth J Shpall; Michael R Green; Sattva S Neelapu; Jason R Westin
Journal:  Blood Adv       Date:  2020-07-14

Review 3.  Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.

Authors:  Sattva S Neelapu; Sudhakar Tummala; Partow Kebriaei; William Wierda; Cristina Gutierrez; Frederick L Locke; Krishna V Komanduri; Yi Lin; Nitin Jain; Naval Daver; Jason Westin; Alison M Gulbis; Monica E Loghin; John F de Groot; Sherry Adkins; Suzanne E Davis; Katayoun Rezvani; Patrick Hwu; Elizabeth J Shpall
Journal:  Nat Rev Clin Oncol       Date:  2017-09-19       Impact factor: 66.675

4.  Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6.

Authors:  Masaki Shimizu; Yasuo Nakagishi; Kazuko Kasai; Yuichi Yamasaki; Mari Miyoshi; Syuji Takei; Akihiro Yachie
Journal:  Cytokine       Date:  2012-03-06       Impact factor: 3.861

5.  A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults.

Authors:  Bharat Kumar; Sohaib Aleem; Hana Saleh; Jennifer Petts; Zuhair K Ballas
Journal:  J Clin Immunol       Date:  2017-09-04       Impact factor: 8.317

6.  Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells.

Authors:  Margherita Norelli; Barbara Camisa; Giulia Barbiera; Laura Falcone; Ayurzana Purevdorj; Marco Genua; Francesca Sanvito; Maurilio Ponzoni; Claudio Doglioni; Patrizia Cristofori; Catia Traversari; Claudio Bordignon; Fabio Ciceri; Renato Ostuni; Chiara Bonini; Monica Casucci; Attilio Bondanza
Journal:  Nat Med       Date:  2018-05-28       Impact factor: 53.440

7.  CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade.

Authors:  Theodoros Giavridis; Sjoukje J C van der Stegen; Justin Eyquem; Mohamad Hamieh; Alessandra Piersigilli; Michel Sadelain
Journal:  Nat Med       Date:  2018-05-28       Impact factor: 53.440

8.  Recommendations for the management of hemophagocytic lymphohistiocytosis in adults.

Authors:  Paul La Rosée; AnnaCarin Horne; Melissa Hines; Tatiana von Bahr Greenwood; Rafal Machowicz; Nancy Berliner; Sebastian Birndt; Juana Gil-Herrera; Michael Girschikofsky; Michael B Jordan; Ashish Kumar; Jan A M van Laar; Gunnar Lachmann; Kim E Nichols; Athimalaipet V Ramanan; Yini Wang; Zhao Wang; Gritta Janka; Jan-Inge Henter
Journal:  Blood       Date:  2019-04-16       Impact factor: 22.113

9.  CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial.

Authors:  Nirali N Shah; Steven L Highfill; Haneen Shalabi; Bonnie Yates; Jianjian Jin; Pamela L Wolters; Amanda Ombrello; Seth M Steinberg; Staci Martin; Cindy Delbrook; Leah Hoffman; Lauren Little; Anusha Ponduri; Haiying Qin; Haris Qureshi; Alina Dulau-Florea; Dalia Salem; Hao-Wei Wang; Constance Yuan; Maryalice Stetler-Stevenson; Sandhya Panch; Minh Tran; Crystal L Mackall; David F Stroncek; Terry J Fry
Journal:  J Clin Oncol       Date:  2020-04-14       Impact factor: 44.544

Review 10.  ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.

Authors:  Daniel W Lee; Bianca D Santomasso; Frederick L Locke; Armin Ghobadi; Cameron J Turtle; Jennifer N Brudno; Marcela V Maus; Jae H Park; Elena Mead; Steven Pavletic; William Y Go; Lamis Eldjerou; Rebecca A Gardner; Noelle Frey; Kevin J Curran; Karl Peggs; Marcelo Pasquini; John F DiPersio; Marcel R M van den Brink; Krishna V Komanduri; Stephan A Grupp; Sattva S Neelapu
Journal:  Biol Blood Marrow Transplant       Date:  2018-12-25       Impact factor: 5.742
View more
  5 in total

1.  Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells.

Authors:  Daniel A Lichtenstein; Fiorella Schischlik; Lipei Shao; Seth M Steinberg; Bonnie Yates; Hao-Wei Wang; Yanyu Wang; Jon Inglefield; Alina Dulau-Florea; Francesco Ceppi; Leandro C Hermida; Kate Stringaris; Kim Dunham; Philip Homan; Parthav Jailwala; Justin Mirazee; Welles Robinson; Karen M Chisholm; Constance Yuan; Maryalice Stetler-Stevenson; Amanda K Ombrello; Jianjian Jin; Terry J Fry; Naomi Taylor; Steven L Highfill; Ping Jin; Rebecca A Gardner; Haneen Shalabi; Eytan Ruppin; David F Stroncek; Nirali N Shah
Journal:  Blood       Date:  2021-12-16       Impact factor: 22.113

2.  Anakinra utilization in refractory pediatric CAR T-cell associated toxicities.

Authors:  Caroline Diorio; Anant Vatsayan; Aimee C Talleur; Colleen Annesley; Jennifer J Jaroscak; Haneen Shalabi; Amanda K Ombrello; Michelle Hudspeth; Shannon L Maude; Rebecca A Gardner; Nirali N Shah
Journal:  Blood Adv       Date:  2022-06-14

3.  Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel.

Authors:  Reyes Maria Martín-Rojas; Ignacio Gómez-Centurión; Rebeca Bailén; Mariana Bastos; Francisco Diaz-Crespo; Diego Carbonell; Rafael Correa-Rocha; Marjorie Pion; Cristina Muñoz; Milagros Sancho; Isabel Gómez Fernández; Gillen Oarbeascoa; Ana Pérez-Corral; Carolina Martínez-Laperche; Javier Anguita; Ismael Buño; Javier Menárguez; Jose Luis Díez-Martín; Mi Kwon
Journal:  Clin Case Rep       Date:  2022-01-07

Review 4.  Cytokine Release Syndrome and Associated Acute Toxicities in Pediatric Patients Undergoing Immune Effector Cell Therapy or Hematopoietic Cell Transplantation.

Authors:  Susanne H C Baumeister; Gopi S Mohan; Alaa Elhaddad; Leslie Lehmann
Journal:  Front Oncol       Date:  2022-03-24       Impact factor: 6.244

Review 5.  Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study.

Authors:  Mohsen Sheykhhasan; Hamed Manoochehri; Paola Dama
Journal:  Cancer Gene Ther       Date:  2022-01-05       Impact factor: 5.854
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.